Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Roche Finalizes Poseida Acquisition: This Cell Therapy Deal Feels Like A Win/Win
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
Health and Me on MSN23h
A New Ozempic? Researchers Develop New Weight Loss Drug That Doesn't Cause Nausea
The drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While these GLP-1 receptor agonists are effective in weight management, they often ...
Hosted on MSN5h
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...
Terry Smith Sells Diageo Stock on Concern Over Weight-Loss Drugs
British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...
Dietetics professor explains who should and should not embrace the latest weight-loss drugs
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...
Healio4h
Novel drug confers weight loss of about 20% at 1 year in phase 2 study
Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...
The New York Times23h
New York
By Emma G. Fitzsimmons The executive director of the New York City Board of Elections made inappropriate sexual and racial remarks toward two employees over a period of several months, a watchdog ...